National Storage Mechanism | Additional information
RNS Number : 6160I
Citadel Group
05 December 2022
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap 19

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.         KEY INFORMATION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Name of person dealing (Note 1)

Citadel Group

Company dealt in

HORIZON THERAPEUTICS PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BQPVQZ61

Date of dealing

02 December, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security

                    dealt in (Note 3)

 

 

 

 

 

 

 

 

Long

Short

ISIN IE00BQPVQZ61

Number        (%)

Number      (%)

(1) Relevant securities

2,755,866 (1.21%)

213,986 (0.09%)

(2) Derivatives (other than options)

0 (0.00%)

12,261 (0.00%)

(3) Options and agreements to purchase/sell

357,520 (0.15%)

175,707 (0.07%)

Total

3,113,386 (1.37%)

401,954 (0.17%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap 20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.         DEALINGS (Note 4)

 

(a)        Purchases and sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase/sale

ISIN IE00BQPVQZ61

Number of securities

Price per unit (Note 5)

Buy Transaction

18

104.8500 USD

Buy Transaction

4,258

103.9829 USD

Buy Transaction

1,179

103.8965 USD

Buy Transaction

217

103.1305 USD

Buy Transaction

194

103.5414 USD

Buy Transaction

100

104.1400 USD

Buy Transaction

85

104.1800 USD

Sell Transaction

18

104.8500 USD

Sell Transaction

180

103.8912 USD

Sell Transaction

466

103.8952 USD

Sell Transaction

1,169

103.8922 USD

Sell Transaction

9,601

104.5829 USD

Sell Transaction

48

104.3475 USD

Sell Transaction

200

104.6475 USD

Sell Transaction

4,752

104.0224 USD

Sell Transaction

188

104.0209 USD

Sell Transaction

360

104.1528 USD

Sell Transaction

712

103.9622 USD

Sell Transaction

1,651

104.0725 USD

Sell Transaction

3,470

104.0644 USD

Sell Transaction

2,100

104.8500 USD

Sell Transaction

33,744

104.8500 USD

DVP Transaction

18

104.8500 USD

DVP Transaction

2,100

104.8500 USD

DVP Transaction

33,762

104.8500 USD

RVP Transaction

33,744

104.8500 USD

RVP Transaction

2,100

104.8500 USD

RVP Transaction

36

104.8500 USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b)        Derivatives transactions (other than options transactions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product name,

e.g. CFD

ISIN IE00BQPVQZ61

Nature of transaction

(Note 6)

 

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Reducing short position

25,000

104.0895 USD

CFD

Reducing short position

24,189

103.6555 USD

CFD

Reducing short position

10,000

104.0894 USD

CFD

Reducing short position

3,750

104.0896 USD

CFD

Reducing short position

1,164

104.2378 USD

CFD

Reducing short position

459

104.2378 USD

CFD

Reducing short position

177

104.2378 USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(c)        Options transactions in respect of existing relevant securities

 

(i)         Writing, selling, purchasing or varying

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product name, e.g. call option

Writing, selling, purchasing,

varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type,

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(Note 5)

Call Option

DVP Transaction

10

105.0000 DOL.C-USAA

Amer Opt

16/12/2022

3.7000 USD

Put Option

DVP Transaction

1

85.0000 DOL.C-USAA

Amer Opt

20/01/2023

2.8500 USD

Call Option

RVP Transaction

10

105.0000 DOL.C-USAA

Amer Opt

16/12/2022

3.7000 USD

Put Option

RVP Transaction

1

85.0000 DOL.C-USAA

Amer Opt

20/01/2023

2.8500 USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)        Exercising

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product name,

e.g. call option

Number of securities

Exercise price per unit

(Note 5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nature of transaction

(Note 8)

      Details

      Price per unit

      (if applicable) (Note 5)

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap 21

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2.         OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated

None

 

 

 

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)

 

NO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Date of disclosure:

05 December, 2022

 Contact name:

Paula Sharp

 Telephone number:

020 7645 9700

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEUPGQWPUPPGGA